In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Akari Therapeutics Plc ADR (NASDAQ: AKTX) was $0.25 for the day, down -1.22% from the previous closing price of $0.25. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 1.88 million shares were traded. AKTX stock price reached its highest trading level at $0.2658 during the session, while it also had its lowest trading level at $0.2419.
Ratios:
Our analysis of AKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.19 and its Current Ratio is at 0.19. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on July 18, 2025, initiated with a Buy rating and assigned the stock a target price of $5.
On January 04, 2019, B. Riley FBR Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $2.50 to $3.
On February 08, 2018, B. Riley FBR Inc. started tracking the stock assigning a Neutral rating and target price of $3.B. Riley FBR Inc. initiated its Neutral rating on February 08, 2018, with a $3 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 21 ’25 when Gaslightwala Abizer bought 10,000 shares for $0.94 per share. The transaction valued at 9,400 led to the insider holds 287,574 shares of the business.
Gaslightwala Abizer bought 8,000 shares of AKTX for $7,440 on Aug 22 ’25. The CEO now owns 295,574 shares after completing the transaction at $0.93 per share. On Aug 25 ’25, another insider, Gaslightwala Abizer, who serves as the CEO of the company, bought 3,000 shares for $0.90 each. As a result, the insider paid 2,700 and bolstered with 298,574 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKTX now has a Market Capitalization of 8952803 and an Enterprise Value of 17905338368.
Stock Price History:
The Beta on a monthly basis for AKTX is 0.31, which has changed by -0.746 over the last 52 weeks, in comparison to a change of 0.15905356 over the same period for the S&P500. Over the past 52 weeks, AKTX has reached a high of $1.73, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -58.11%, while the 200-Day Moving Average is calculated to be -74.61%.
Shares Statistics:
AKTX traded an average of 780.59K shares per day over the past three months and 1284200 shares per day over the past ten days. A total of 32.61M shares are outstanding, with a floating share count of 32.48M. Insiders hold about 0.40% of the company’s shares, while institutions hold 3.62% stake in the company. Shares short for AKTX as of 1764288000 were 69172 with a Short Ratio of 0.09, compared to 1761868800 on 138681. Therefore, it implies a Short% of Shares Outstanding of 69172 and a Short% of Float of 0.29.
